SCHEMBL7988672

SCHEMBL7988672

NCCc1nc2ncn(Cc3cccc(Cl)c3)c2c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.47
ALDH1A1 P00352 2/20 0.47
GLA P06280 1/20 0.47
HTT P42858 1/20 0.47
UBE2N P61088 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KMT2A Q03164 1/20 0.46
HPGD P15428 1/20 0.45
HCAR2 Q8TDS4 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41
ACP1 P24666 1/20 0.40
YTHDC1 Q96MU7 2/20 0.40
MAPK1 P28482 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3CB P42338 1/20 0.40
HTR6 P50406 1/20 0.39
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
FSCN1 Q16658 1/20 0.39
TUBB4A P04350 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991723 0.89 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1GLAHTTUBE2N
SCHEMBL7985634 0.89 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1KMT2AHPGDHCAR2
Hydrochloric Acid SCHEMBL7987615 0.88 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDHCAR2
SCHEMBL7992185 0.87 HPGD (0.45) SMN1; SMN2ALDH1A1HTTKMT2AHPGD
SCHEMBL7988531 0.87 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDHCAR2
SCHEMBL7984753 0.87 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1GLAHTTUBE2N
SCHEMBL7985271 0.85 GAA (0.51) SMN1; SMN2ALDH1A1KMT2AHPGDHCAR2
SCHEMBL7987671 0.84 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1GLAHTTUBE2N
Hydrochloric Acid SCHEMBL7987800 0.83 HPGD (0.48) SMN1; SMN2ALDH1A1GLAHTTUBE2N
SCHEMBL7988676 0.83 SMN1; SMN2 (0.47) SMN1; SMN2GLAHTTUBE2NL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed